We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2345:TWSEAccton Technology Corp. Analysis

Data as of 2026-03-11 - not real-time

NT$1,490.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Accton Technology is trading at TWD 1,490, roughly 13% below its DCF‑derived fair value of TWD 1,694, suggesting a notable undervaluation. The stock sits comfortably above its 20‑day (TWD 1,348), 50‑day (TWD 1,251) and 200‑day (TWD 1,001) moving averages, and the MACD histogram remains positive (≈4.8) with a bullish crossover, while the RSI of 62 indicates continued momentum without being overbought. Fundamentally, the company delivers exceptional returns – a ROE of 57% and ROA of 17% alongside a solid cash pile of TWD 42.99 bn and a modest debt load (debt‑to‑equity ≈6.7%). The dividend yield of 0.77% is backed by a low payout ratio (~27%), reinforcing sustainability. However, a 30‑day volatility of 68% and a decreasing volume trend flag heightened price swings, though the beta near 0.9 tempers market‑wide systematic risk. Overall, the blend of strong growth drivers in AI/ML networking, robust cash generation, and an attractive upside target supports a bullish outlook across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above key moving averages
  • Current price below resistance and fair‑value upside
  • Strong cash flow supporting near‑term stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~13% and undervalued relative to peers
  • High ROE and low debt enhancing financial resilience
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Growth exposure to AI/ML fabrics and edge‑computing markets
  • Consistently strong cash generation and balance‑sheet health
  • Long‑term undervaluation and attractive dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth158.70%
Profit Margin10.46%
P/E Ratio37.2
ROE57.04%
ROA17.01%
Debt/Equity6.73
P/B Ratio16.8
Op. Cash FlowNT$28.0B
Free Cash FlowNT$23.7B
Industry P/E36.8

Technical Analysis

TrendBullish
RSI62.0
SupportNT$1,090.00
ResistanceNT$1,515.00
MA 20NT$1,347.75
MA 50NT$1,251.40
MA 200NT$1,001.26
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair ValueNT$1,694.03
Target PriceNT$1,683.57
Upside/Downside12.99%
GradeUndervalued
TypeBlend
Dividend Yield0.77%

Risk Assessment

Beta0.89
Volatility68.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.